⚡ Ten Kliks South Analysis

Sunday, October 24, 2021 8:49:53 AM

Ten Kliks South Analysis

Ko, Ten Kliks South Analysis. In the s cartoon, Scorpia had sunken cheeks, garish eye makeup, and The Importance Of Academic English angular face. You need to login to do this. Ten Kliks South Analysis burning Ten Kliks South Analysis. In fact, the opposite has usually Ten Kliks South Analysis observed; Ten Kliks South Analysis is, viremias are usually higher in primary infections. OhAinle, M.

Savings plan analysed - more than 100% commission?!

The virus multiplies in then disables and kills macrophages. ADE in vivo has been demonstrated by challenging animals sensitized by passively transferred antibodies [ 98 , 99 ]. Reminiscent of dengue, the literature on pathogenesis focuses heavily on the disease-producing role of cytokines [ 97 ]. PRRSV infects lymphoid tissues and is often chronic. Infected animals are at increased risk for a variety of microbial infections.

Once a herd is infected the virus tends to remain present and active indefinitely. Some live-attenuated vaccines have provided short-term protection. Enhanced viremia and tissue infection has been described in vaccinated animals experiencing breakthrough PRRSV infections [ ]. Investigators have attributed vaccine failure to ADE [ ]. Influenza A viruses cause acute respiratory infections, resulting in severe economic losses to domestic animals.

Although influenza pandemics in birds create headlines, there are no reports of vaccine-enhanced disease [ ]. However, VAED is a well-established outcome of influenza vaccines of swine. Swine influenza results in significant economic losses for global pig production. The origin, genetic background, and antigenic properties of IAV-S vary considerably from region to region. Pigs have played a role in the adaptation of avian influenza A viruses from avian reservoirs to humans and other mammalian hosts. For these many reasons, efforts are made to control porcine influenza by vaccines.

It is well established that inactivated whole virion vaccines sensitize pigs to a breakthrough respiratory syndrome similar to VAH [ ]. The challenge of achieving vaccines that safely and durably protect against human RSV and influenza is reminiscent of the difficulty in obtaining vaccines for diverse viral diseases that threaten commercial agriculture. Many of those who have been recently introduced to the dengue literature mistakenly assume that antibody-enhanced infection is itself a pathology. It is not. ADE controls the rate of intracellular virus production and total number of cells infected. It is NS1, a circulating viral toxin of endothelial cells, that produces the dengue shock syndrome, an analog of bacterial endotoxin septic shock.

The mechanism s by which viral immune complexes, once introduced into FcR-bearing cells, affect replicative outcome are not well understood and have attracted surprisingly little interest [ ]. Inflammatory responses following the introduction of pathogenic micro-organisms into partially immune hosts are difficult to unravel as illustrated in RSV VAH animal models. Future research should approach ADE and VAH as independent systems, one involving infection amplification and the other leading to a pathologic process. National Center for Biotechnology Information , U. Scott B. Author information Article notes Copyright and License information Disclaimer. Halstead, Email: moc. Corresponding author. Accepted Aug 2. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source.

Abstract Vaccine-associated enhanced disease VAED is a serious barrier to attaining successful virus vaccines in human and veterinary medicine. Key Points Human and veterinary vaccines may sensitize to enhanced breakthrough virus infections. At least two mechanisms of sensitization, antibody-dependent enhancement and vaccine-associated hypersensitivity, are identified. Vaccine safety requires studies designed to identify and avoid virus vaccine-enhanced disease. Open in a separate window. Vaccine-Associated Enhanced Disease VAED Antibody-Dependent Enhancement ADE ADE is a generic phenomenon of Fc-receptor-bearing target cells in which increased intracellular replication occurs when infecting micro-organisms are presented as immune complexes in contrast to infection by naked micro-organisms [ 14 , 15 ].

Dengue ADE in Vaccinated Humans: Yellow Fever Chimeric Vaccine Viable viral chimeras were obtained when genes of structural virus proteins of one flavivirus were introduced into a backbone of another [ 41 ]. Dengue Vaccine ADE in Laboratory Animals: Formalin-Inactivated Whole Virus Dengue vaccine development started in when virus in blood or mosquitoes was inactivated with phenol, formalin, or bile and inoculated in human volunteers who were then challenged with live virus [ 50 , 51 ]. Discussion There is a large literature of vaccine failures in veterinary medicine, some of which are accompanied by enhanced breakthrough disease [ 89 — ]. Table 1 Observed in vitro ADE and enhanced viral diseases in animals sensitized by administration of vaccines.

Declarations Funding no funding was received. References 1. Ricke DO. Front Immunol. Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population.

Am J Epidemiol. Effect of dengue serostatus on dengue vaccine safety and efficacy. N Engl J Med. Ethics of a partially effective dengue vaccine: lessons from the Philippines. Immunologic phenomena in the effusive form of feline infectious peritonitis. Am J Vet Res. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp Immune Microbiol Infect Dis.

Pedersen NC. An update on feline infectious peritonitis: diagnostics and therapeutics. Vet J. Ubol S, Halstead SB. How innate immune mechanisms contribute to antibody-enhanced viral infections. Clin Vaccine Immunol. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge.

J Virol. JCI Insight. Halstead SB, Katzelnick L. J Infect Dis. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis. Cell type specificity and host genetic polymorphisms influence antibody dependent enhancement of dengue virus infection. Hawkes RA. Enhancement of the infectivity of arboviruses by specific antisera produced in domestic fowls. Kliks S, Halstead SB. An explanation for enhanced virus plaque formation in chick embryo cells.

Halstead SB. In vivo enhancement of dengue virus infection in Rhesus monkeys by passively transferred antibody. Hemorrhagic fever observed among children in the Philippines. Philipp J Pediatr. New hemorrhagic fevers of children in the Philippines and Thailand. Trans Assoc Am Phys. Hemorrhagic fever in Thailand; recent knowledge regarding etiology. Jpn J Med Sci Biol. Observations related to pathogenesis of dengue hemorrhagic fever. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. Dengue viruses and mononuclear phagocytes.

Infection enhancement by non-neutralizing antibody. J Exp Med. Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar. Hum Pathol. Pathogenesis of dengue: challenges to molecular biology. Dengue antibody-dependent enhancement: knowns and unknowns. Microbiol Spectrosc. Arch Virol. Shock associated with dengue infection. Clinical and physiologic manifestations of dengue hemorrhagic fever in Thailand, J Pediatr. The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci Transl Med. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis.

Rothman A. Dengue immune response: low affinity, high febrility. Nat Med. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand. Zika virus infection enhances future risk of severe dengue disease. Enhancement of dengue virus infection in monocytes by flavivirus antisera. Am J Trop Med Hyg. Dengue: guidelines for diagnosis, treatment prevention and control.

WHO; PLoS Pathog. Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge. Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. Who Global advisory committee on vaccine safety, 15—16 June Wkly Epidemiol Rec. Yoksan S. Short history of dengue and Mahidol dengue vaccine. Testing of a dengue 2 live-attenuated vaccine strain PDK 53 in ten American volunteers.

Efficacy of a tetravalent dengue vaccine in healthy children and adolescents. Efficacy of a dengue vaccine candidate TAK in healthy children and adolescents two years after vaccination. Experimental studies of dengue. Philipp J Sci. Blanc G, Caminopetros J. Recherches experimentales sur la dengue. Ann Inst Pasteur Paris. Immunogenic and protective response in mice immunized with a purified, inactivated, Dengue-2 virus vaccine prototype made in fetal rhesus lung cells. An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model. An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques.

Safety and immunogenicity of a dengue virus serotype-1 purified-inactivated vaccine: results of a phase 1 clinical trial. Phase 1 randomized study of a tetravalent dengue purified inactivated vaccine in healthy adults from Puerto Rico. Safety and immunogenicity of an AS03 B -adjuvanted inactivated tetravalent dengue virus vaccine administered on varying schedules to healthy U.

Detection of post-vaccination enhanced dengue virus infection in macaques: an improved model for early assessment of dengue vaccines. Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region. Robust and balanced immune responses to all 4 dengue virus serotypes following administration of a single dose of a live attenuated tetravalent dengue vaccine to healthy, flavivirus-naive adults. The live attenuated dengue vaccine TV elicits complete protection against dengue in a human challenge model.

Complexity of neutralization antibodies against multiple dengue viral serotypes after heterotypic immunization and secondary infection revealed by in-depth analysis of cross-reactive antibodies. Dengue in Brazil in what happened? Buser F. Side reaction to measles vaccination suggesting the arthus phenomenon. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. A role for immune complexes in enhanced respiratory syncytial virus disease. Polack FP.

Atypical measles and enhanced respiratory syncytial virus disease ERD made simple. Pediatr Res. Brief history and characterization of enhanced respiratory syncytial virus disease. Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease.

Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the Bonnet monkey model. Neutralizing and enhancing activities of human respiratory syncytial virus-specific antibodies. Clin Diagn Lab Immunol. Cutting edge: biasing immune responses by directing antigen to macrophage Fc gamma receptors. J Immunol. A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines. Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara MVA expressing respiratory syncytial virus proteins. Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity.

J Clin Microbiol. A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles. Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection. The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice. Curr Opin Virol. Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates.

ACS Infect Dis. Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic. Early death after feline infectious peritonitis challenge due to recombinant vaccinia virus immunization. Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Aleutian disease of mink. Adv Immunol. Eenie, Meenie, Miney, Moe, who is responsible for the antibody-dependent enhancement of Aleutian mink disease parvovirus infection?. Chin J Virol. The pathogenesis of Aleutian disease of mink. In vivo viral replication and the host antibody response to viral antigen.

Enhancement of tissue lesions following the administration of a killed virus vaccine or passive antibody. Plagemann PG. However, it has a slightly higher sensitivity than the HI test. A number of commercial test kits for anti-dengue IgM and IgG antibodies have become available in the past few years. Unfortunately, the accuracy of most of these tests is unknown because proper validation studies have not been done. Some evaluations have been published 91 , 96 , , , but the sample sizes have been too small to accurately measure sensitivity and specificity.

Moreover, the samples generally used have represented only strong positives and negatives, with few samples representing optical densities or positive-negative values in the equivocal range. One exception to this were kits that were independently evaluated at CDC; both IgM and IgG test kits had a high rate of false-positive results compared to standard tests, especially with samples with optical densities in the equivocal range Other studies, however, have given results comparable to those of standard tests 96 , , It is anticipated that these test kits can be reformulated to make them more accurate, making global laboratory-based surveillance for dengue and DHF an attainable goal in the near future.

Four isolation systems have routinely been used for dengue viruses; intracerebral inoculation of 1- to 3-day-old baby mice, the use of mammalian cell cultures primarily LLC-MK 2 cells , intrathoracic inoculation of adult mosquitoes, and the use of mosquito cell cultures 47 , 55 , Although all four dengue serotypes were initially isolated from human serum by using baby mice 70 , 74 , , this method is very time-consuming, slow, and expensive.

Moreover, because of the low sensitivity of the method, many wild-type viruses cannot be isolated with baby mice. Those that are isolated frequently require numerous passages to adapt the viruses to growth in mice. This method is no longer recommended for isolation of dengue viruses, but some laboratories continue to use it One advantage of using baby mice, however, is that other arboviruses that cause dengue-like illness may be isolated with this system.

Mammalian cell cultures have many of the same disadvantages as baby mice for isolation of dengue viruses—they are expensive, slow, and insensitive 47 , 55 , , As with isolation systems that use baby mice, viruses that are isolated frequently require many passages before a consistent cytopathic effect can be observed in the infected cultures. Although the use of this method continues in some laboratories, it is not recommended 47 , Mosquito inoculation is the most sensitive method for dengue virus isolation 47 , Moreover, there are many endemic dengue virus strains that can be recovered only by this method 47 , 49 , Four mosquito species have been used for virus isolation, A.

Male and female mosquitoes are equally susceptible; dengue viruses generally replicate to high titers 10 6 to 10 7 MID 50 in as little as 4 to 5 days, depending on the temperature of incubation. Dengue viruses replicate in most mosquito tissues, including the brain. A recent variation on this method involves intracerebral inoculation of larval and adult Toxorhynchities mosquitoes 95 , However, these modifications neither increase sensitivity nor provide other advantages over intrathoracic inoculation Virus detection in the mosquito, regardless of the species, is generally performed by the direct fluorescent-antibody DFA test on mosquito tissues, usually brain or salivary glands 47 , 50 , The direct conjugate is prepared from pooled human serum and has broadly reactive anti-dengue or anti-flavivirus activity.

Alternatively, a polyclonal mouse ascitic fluid or a flavivirus group-reactive monoclonal antibody can be used in an indirect fluorescent-antibody IFA test with an anti-mouse immunoglobulin G—fluorescein isothiocyanate conjugate that is commercially available. The mosquito inoculation technique has the disadvantages of being labor-intensive and requiring an insectary to produce large numbers of mosquitoes for inoculation. Also, unless strict safety precautions are maintained, the chance of laboratory infections increases, although this risk can be eliminated by using male Aedes mosquitoes or nonbiting Toxorhynchites species for inoculation 47 , Mosquito cell cultures are the most recent addition to dengue virus isolation methodology 47 , 52 , 76 , 88 , Three cell lines of comparable sensitivity are most frequently used The use of these cell lines has provided a rapid, sensitive, and economical method for dengue virus isolation.

Moreover, many serum specimens can be processed easily, making the method ideal for routine virologic surveillance However, this system is less sensitive than mosquito inoculation However, the sensitivity of the mosquito cell lines may vary with the strain of virus. In samples from an epidemic in Mozambique, more than twice as many DEN-3 viruses were isolated by mosquito inoculation than by the use of mosquito cells Dengue antigen can be detected in infected-cell cultures by DFA or IFA tests with the conjugates used for mosquito tissues Some workers, however, prefer to use cytopathic effect to detect infection, especially with AP cells.

However, this method alone will miss many dengue viruses that do not replicate rapidly in mosquito cells The methods selected for virus isolation depend upon the laboratory facilities available. Because the mosquito inoculation technique is the most sensitive, it is the method of choice for fatal cases or patients with severe hemorrhagic disease. Use of the mosquito cell lines is the method of choice for routine virologic surveillance. Even though cell cultures are less sensitive than mosquito inoculation, this disadvantage is more than offset by the ease with which large numbers of samples can be processed in a relatively short time.

The method of choice for dengue virus identification is IFA with serotype-specific monoclonal antibodies produced in tissue culture or mouse ascitic fluids and an anti-mouse immunoglobulin G-fluorescein isothiocyanate conjugate 47 , 52 , 55 , This test can be easily performed with infected cell cultures, mosquito brain or tissue squashes, mouse brain squashes, or even on formalin-fixed tissues embedded in paraffin and sectioned for histopathologic testing It is simple and reliable and is the most rapid method. Moreover, it allows the detection of multiple viruses in patients with concurrent infections with more than one serotype 53 , The success of isolating dengue virus from human serum depends on several factors First, the manner in which the specimen has been handled and stored is important.

Virus activity can be inhibited by heat, pH, and several chemicals; therefore, improper handling is often an important cause of unsuccessful virus isolation. Viremia usually peaks at or shortly before the onset of illness and may be detectable for an average of 4 to 5 days 43 , 47 , 51 , The success of virus isolation decreases rapidly with the appearance of IgM antibody 47 , With some virus strains, however, viremia may remain below the level of detectability throughout the illness 47 , Finally, the virus isolation system used influences the success of isolation, as discussed above.

In recent years, several new methods of diagnosis have been developed and have proven very useful in dengue diagnosis. This topic has recently been reviewed extensively The various methods are discussed briefly below. The method is rapid, sensitive, simple, and reproducible if properly controlled and can be used to detect viral RNA in human clinical samples, autopsy tissues, or mosquitoes 29 , 55 , 98 , A number of methods involving primers from different locations in the genome and different approaches to detect the RT-PCR products have been developed over the past several years 29 , 55 , The availability of virus isolates is important for characterizing virus strain differences, since this information is critical for viral surveillance and pathogenesis studies.

Since RT-PCR is highly sensitive to amplicon contamination, without proper controls false-positive results may occur. Improvements in this technology, however, should make it even more useful in the future 29 , The hybridization probe method detects viral nucleic acids with cloned hybridization probes 29 , Probes with variable specificity ranging from dengue complex to serotype specific can be constructed depending on the genome sequences used. The method is rapid and relatively simple and can be used on human clinical samples as well as fixed autopsy tissues.

Unfortunately, hybridization probes have not been widely used or evaluated in the diagnostic laboratory. Preliminary data suggest that this method is less sensitive than RT-PCR, but like PCR, the outcome of the test is not influenced by the presence of neutralizing antibodies or other inhibitory substances. Even so, the difficulties of working with RNA and the technical expertise required to obtain reproducible results make this method more suitable as a research tool than as a routine diagnostic test 29 , 30 , A major problem in dengue laboratory diagnosis has been confirmation of fatal cases. In most instances, only a single serum sample is obtained and serologic testing is therefore of limited value.

Also, most patients die at the time of or slightly after defervescence, when virus isolation is difficult. With new methods of immunohistochemistry, it is now possible to detect dengue viral antigen in a variety of tissues 56 , Although immunofluorescence tests were used in the past, newer methods involving enzyme conjugates such as peroxidase and phosphatase in conjunction with either polyclonal or monoclonal antibodies are greatly improved Because tissues can be fresh or fixed, autopsies should be performed in all cases of suspected DHF with a fatal outcome 47 , Prevention and control of dengue and DHF has become more urgent with the expanding geographic distribution and increased disease incidence in the past 20 years 36 , 39 , 41 , 42 , 45 , 48 , 61 , 63 , Unfortunately, tools available to prevent dengue infection are very limited.

There is no vaccine currently available see below , and options for mosquito control are limited. Clearly, the emphasis must be on disease prevention if the trend of emergent disease is to be reversed. Effective disease prevention programs must have several integrated components, including active laboratory-based surveillance, emergency response, education of the medical community to ensure effective case management, community-based integrated mosquito control, and effective use of vaccines when they become available 37 , The first candidate dengue vaccines were developed shortly after the viruses were first isolated by Japanese and American scientists 81 , Despite considerable work over the years, an effective safe vaccine was never developed 3 , 59 , 69 , , The World Health Organization designated the development of a tetravalent dengue vaccine a priority for the most cost-effective approach to dengue prevention 13 , Effective vaccination to prevent DHF will most probably require a tetravalent vaccine, because epidemiologic studies have shown that preexisting heterotypic dengue antibody is a risk factor for DHF 18 , 57 , 61 , 62 , With the support of the World Health Organization, considerable progress in developing a vaccine for dengue and DHF has been made in recent years 8 , 10 , 11 , , Promising candidate attenuated vaccine viruses have been developed and have been evaluated in phase I and II trials in Thailand as monovalent, bivalent, trivalent, and tetravalent formulations 8.

A commercialization contract has been signed, and the tetravalent vaccine formulation is currently undergoing repeat phase I trials in the United States. Current progress on the live attenuated dengue vaccine has been recently reviewed 8. Promising progress in the development of alternative vaccine strategies using new molecular technology has also been made in recent years. Recent approaches include the use of inactivated whole-virion vaccines 23 , synthetic peptides 5 , , , subunit vaccines 31 , , , vector expression, recombinant live vector systems 23 , , infectious cDNA clone-derived vaccines 16 , 25 , 79 , 80 , 82 , 93 , , and naked DNA 24 , The last two approaches appear to be the most promising.

Through genetic manipulation, these recombinants may be made to grow better and to be more immunogenic and safer than the original live attenuated virus vaccine candidates. In addition, chimeras are being constructed by inserting the structural proteins of dengue viruses into the infections clones of the 17D yellow fever and the SA Japanese encephalitis vaccine viruses a. The development of naked DNA vaccines is in its infancy but shows great promise This area has been recently reviewed 23 , Despite the promising progress, it is unlikely that an effective, safe, and economical dengue vaccine will be available in the near future.

A major problem has been and continues to be lack of financial support for dengue vaccine research. Thus, other approaches to disease prevention must be developed by using the program components outlined above. Active disease surveillance is an important component of a dengue prevention program. In addition to monitoring secular trends, the goal of surveillance should be to provide an early-warning or predictive capability for epidemic transmission, the rationale being that if epidemics can be predicted, they can be prevented by initiating emergency mosquito control. For epidemic prediction, health authorities must be able to accurately monitor dengue virus transmission in a community and be able to tell at any point in time where transmission is occurring, which virus serotypes are circulating, and what kind of illness is associated with dengue infection 44 , To accomplish this, the system must be active and laboratory based.

This type of proactive surveillance system must have at least three components that place the emphasis on the inter- or preepidemic period. The sentinel clinic and physician network and fever alert system are designed to monitor nonspecific viral syndromes in the community. This is especially important for dengue viruses because they are frequently maintained in tropical urban centers in a silent or unrecognized transmission cycle, often presenting as nonspecific viral syndromes. The sentinel clinic and physician network and fever alert system are also very useful for monitoring other common infectious diseases such as influenza, measles, malaria, typhoid, and leptospirosis.

In contrast to the sentinel clinic and physician component, which requires sentinel sites to monitor routine viral syndromes, the fever alert system relies on community health and sanitation workers to be alert to any increase in febrile activity in their community and to report this to the central epidemiology unit of the health department. Investigation by the health department should be immediate but flexible; it may involve telephone follow-up or active investigation by an epidemiologist who visits the area to take samples.

The sentinel hospital component should be designed to monitor severe disease. Hospitals used as sentinel sites should include all of those that admit patients for severe infectious diseases in the community. This network should also include infectious-disease physicians, who usually consult on such cases. All three proactive surveillance components require a good public health laboratory to provide diagnostic support in virology, bacteriology, and parasitology. The supporting laboratory does not have to be able to test for all agents but should know where to refer specimens for testing, e.

This proactive surveillance system is designed to monitor disease activity during the interepidemic period, prior to epidemic transmission. Individually, the three components are not sensitive enough to provide effective early warning, but when used collectively, they can often accurately predict epidemic activity It must be emphasized that once epidemic transmission has begun, the surveillance system should be refocused on severe disease rather than viral syndromes.

The surveillance system should be designed and adapted to the local conditions where it will be initiated. However, this system should be closely tied to the mosquito control programs that will be responsible for reacting to surveillance data to initiate emergency disease prevention in all areas. Prevention and control of dengue and DHF currently depends on controlling the mosquito vector, A. Space sprays with insecticides to kill adult mosquitoes are not usually effective 38 , , unless they are used indoors. The most effective way to control the mosquitoes that transmit dengue is larval source reduction, i.

There are two approaches to effective A. In the past, the most effective programs have had a vertical, paramilitary organizational structure with a large staff and budget These successful programs were also facilitated by the availability of residual insecticides, such as DDT, that contributed greatly to ridding the mosquito from the domestic environment. Unfortunately, in all of these programs, without exception, there has been no sustainability, because once the mosquito and the disease were controlled, limited health resources were moved to other competing programs and the A. The most recent example of this lack of sustainability is Cuba, where A.

The vertically structured Cuban program has recently failed, most probably because of lack of support; the result was a major dengue epidemic in 2 , In recent years, emphasis has been placed on community-based approaches to larval source reduction to provide program sustainability The rationale is that sustainable A. Community participation in and ownership of prevention programs require extensive health education and community outreach. Unfortunately, this approach is a very slow process.

Therefore, it has been proposed that a combination top-down and bottom-up approach be used, the former to achieve immediate success and the latter to provide program sustainability The effectiveness of this approach remains unknown. Mosquito control for dengue prevention has recently been reviewed There is no completely effective method of preventing dengue infection in travelers visiting tropical areas. The risk of infection can be significantly decreased, however, by understanding the basic behavior and feeding habits of the mosquito vector and by taking a few simple precautions to decrease exposure to infective mosquito bites. Female A. Although the risk may be higher at these times, it is important to remember that the mosquito may feed indoors at anytime during the day as well as outdoors, especially on overcast days.

Precautions, therefore, include staying in screened or air-conditioned rooms, spraying these rooms with aerosol bomb insecticides to kill adult mosquitoes indoors especially in bedrooms , using a repellent containing dimethyl-metatoluamide DEET on exposed skin, and wearing protective clothing treated with a similar repellant. The risk of exposure may be lower in modern, air-conditioned hotels with well-kept grounds and in rural areas. National Center for Biotechnology Information , U. Journal List Clin Microbiol Rev v. Clin Microbiol Rev. Duane J. Author information Copyright and License information Disclaimer. Department of Health and Human Services, P. Box , Fort Collins, Colorado Box , Fort Collins, CO Phone: Fax: E-mail: vog. Copyright notice. This article has been cited by other articles in PMC.

Abstract Dengue fever, a very old disease, has reemerged in the past 20 years with an expanded geographic distribution of both the viruses and the mosquito vectors, increased epidemic activity, the development of hyperendemicity the cocirculation of multiple serotypes , and the emergence of dengue hemorrhagic fever in new geographic regions. Open in a separate window. DHF in the Americas before and from to the present. World distribution map of dengue and A. Factors Responsible for the Increased Incidence The factors responsible for the dramatic resurgence and emergence of epidemic dengue and DHF, respectively, as a global public health problem in the past 17 years are complex and not fully understood.

Transmission Cycles The primitive enzootic transmission cycle of dengue viruses involves canopy-dwelling Aedes mosquitoes and lower primates in the rain forests of Asia and Africa Fig. Dengue Fever Classic dengue fever is primarily a disease of older children and adults. Dengue Hemorrhagic Fever DHF is primarily a disease of children under the age of 15 years, although it may also occur in adults 1 , Host Immune Factors There is a large body of evidence, mostly obtained in vitro, suggesting that heterotypic, nonneutralizing antibody binds with dengue virus, facilitating the entry of the virus into cells of the monocytic line and hence facilitating infection 15 , 61 , 62 , 67 , 68 , Virus Isolation Four isolation systems have routinely been used for dengue viruses; intracerebral inoculation of 1- to 3-day-old baby mice, the use of mammalian cell cultures primarily LLC-MK 2 cells , intrathoracic inoculation of adult mosquitoes, and the use of mosquito cell cultures 47 , 55 , Baby mice.

Mammalian cell culture. Mosquito inoculation. Mosquito cell culture. Virus Identification The method of choice for dengue virus identification is IFA with serotype-specific monoclonal antibodies produced in tissue culture or mouse ascitic fluids and an anti-mouse immunoglobulin G-fluorescein isothiocyanate conjugate 47 , 52 , 55 , New Diagnostic Technology In recent years, several new methods of diagnosis have been developed and have proven very useful in dengue diagnosis.

Hybridization probes. Vaccine Development The first candidate dengue vaccines were developed shortly after the viruses were first isolated by Japanese and American scientists 81 , Disease Prevention Programs Active surveillance. After an epidemic begins and after the virus serotype s is known, the case definition should be made more specific and surveillance should be focused on severe disease.

Mosquito control. Prevention of Dengue in Travelers There is no completely effective method of preventing dengue infection in travelers visiting tropical areas. Dengue hemorrhagic fever, diagnosis, treatment and control. Geneva, Switzerland: World Health Organization; Dengue in the Americas—time to talk. Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers. J Infect Dis. Fatal hemorrhagic disease and shock associated with primary dengue infection on a pacific island. Am J Trop Med Hyg. Becker Y. Virus Genes. Bhamarapravati, N. Hemostatic defects in dengue hemorrhagic fever. Bhamarapravati N. Pathology of dengue infections.

Dengue and dengue hemmorhagic fever. Live attenuated tetravalent dengue vaccine. Dengue and dengue hemorrhagic fever. Pathology of Thailand hemorrhagic fever: a study of autopsy cases. Ann Trop Med Parasitol. Bhamarapravati N, Yoksan S. Study of bivalent dengue vaccine in volunteers. Immunization with a live attenuated dengue-2 virus candidate vaccine PDK 53 : clinical, immunological and biological responses in adult volunteers. Bull W H O. Bielefeldt-Ohmann H. Pathogenesis of dengue virus diseases: missing pieces in the jigsaw. Trends Microbiol. Brandt W E.

Current approaches to the development of dengue vaccines and related aspects of the molecular biology of flaviviruses. Development of dengue and Japanese encephalitis vaccines. Infection enhancement of dengue-2 virus in the U human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect Immun. Bray M, Lai C-J.

Construction of intertypic chimeric dengue viruses by substitution of structural protein genes. Antibody capture immunoassay detection of Japanese encephalitis virus immunoglobulin M and G antibodies in cerebrospinal fluid. J Clin Microbiol. A prospective study of dengue infections in Bangkok. Carey D E. Chikungunya and dengue: a case of mistaken identity? J Hist Med Allied Sci. Casey H L. Standardized diagnostic complement fixation method and adaptation to micro-test. Public health monograph Washington, D. C: Government Printing Office; Centers for Disease Control and Prevention. Imported dengue—United States, and Morbid Mortal Weekly Rep. Unpublished data. Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization Meeting.

Chang, G. Personal communication. Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice. J Virol. Chungue E. Molecular epidemiology of dengue viruses. Factors in the emergence of arbovirus diseases. Paris, France: Elsevier; Clarke D H, Casals J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Deubel V. The contribution of molecular techniques to the diagnosis of dengue infection. Deubel V, Pierre V. Molecular techniques for rapid and more sensitive detection and diagnosis of flaviviruses. Rapid methods and automation in microbiology and immunology. Andover, United Kingdom: Intercept; Processing, secretion, and immunoreactivity of caboxy terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculoviruses.

The dengue and dengue hemorrhagic fever epidemic in Puerto Rico: epidemiologic and clinical observations. P R Health Sci J. Dulbecco R. A study of the basic aspects of neutralization of two animal viruses, Western equine encephalitis virus and poliomyelitis virus. Pandemic dengue in Caribbean countries and the southern United States: past, present and potential problems. N Engl J Med. Epidemic dengue hemorrhagic fever in rural Indonesia: clinical studies.

Gubler D J. Dengue and dengue hemorrhagic fever in the Americas. In: Monath T P, editor. Epidemiology of arthropod-borne viral diseases. Aedes aegypti and Aedes aegypti -borne disease control in the s: top down or bottom up. In: Thoncharoen P, editor. Arboviruses as imported disease agents: the need for increased awareness. Arch Virol. Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem.

Gubler, D. Singapore, in press. A program for prevention and control of epidemic dengue and dengue hemorrhagic fever in Puerto Rico and the U. Emerg Infect Dis. Gubler D J, Rosen L. A simple technique for demonstrating transmission of dengue viruses by mosquitoes without the use of vertebrate hosts. Laboratory diagnosis of dengue and dengue hemorrhagic fever. Infect Agents Dis. Epidemiologic, clinical and virologic observations on dengue in the Kingdom of Tonga.

Virological surveillance for dengue haemorrhagic fever in Indonesia using the mosquito inoculation technique. Viremia in patients with naturally acquired dengue infection. Use of mosquito cell cultures and specific monoclonal antibodies for routine surveillance of dengue viruses. A case of natural concurrent human infection with two dengue viruses. Dengue 3 virus transmission in Africa. Guzman M G, Kouri G. Advances in dengue diagnosis. Clin Diagn Lab Immunol. Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin embedded human liver by immunohistochemical analysis. Halstead S B. Observations related to pathogenesis of dengue hemorrhagic fever. Hypotheses and discussion. Yale J Biol Med. Etiologies of the experimental dengues of Siler and Simmons.

Studies on the attenuation of dengue 4. Asian J Infect Dis. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. Dengue hemorrhagic fever—public health problem and a field for research. Pathogenesis of dengue: challenges to molecular biology. The XXth century dengue pandemic: need for surveillance and research. Rapp Trimest Stat Sanit Mond. Studies on the pathogenesis of dengue infection in monkeys. Clinical laboratory responses to primary infection. Clinical laboratory responses to heterologous infection.

Antibody-enhanced dengue virus infection in primate leukocytes. Nature London ; — Dengue viruses and mononuclear phagocytes. Infection enchancement by non-neutralizing antibody. J Exp Med. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J Immunol. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. Attributes of uncloned virus at different passage levels. New hemorrhagic fevers of children in the Philippines and Thailand. Trans Assoc Am Physicians. Pediatr Infect Dis J. Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay.

Hirsch A. Handbook of geographical and historical pathology. London, United Kingdom: Syndenham Society; Dengue, a comparatively new disease: its symptoms; pp. Hotta S, Kimura R. Experimental studies on dengue 1. Isolation identification and modification of the virus. Howe G M. A world geography of human diseases. New York, N. Y: Academic Press, Inc. Igarashi A. J Gen Virol. Innis B L. In: Porterfield J S, editor. Exotic viral infections— An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Genetic determinants of dengue type 4 virus neurovirulence for mice. Kimura R, Hotta S. Studies on dengue: anti-dengue active immunization experiments in mice.

Jpn J Bacteriol. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice. Reemergence of dengue in Cuba: a epidemic in Santiago de Cuba. Kuberski T T, Rosen L. A simple technique for the detection of dengue antigen in mosquitoes by immunofluorescence. Clinical and laboratory observations on patients with primary and secondary dengue type 1 infections with hemorrhagic manifestations in Fiji. Comparative sensitivity of three mosquito cell lines for isolation of dengue viruses.

J Virol Methods. Use of original antigenic sin theory to determine the serotypes of previous dengue infections. Kuno, G. Cropp, J. Wong-Lee, and D. Dengue IgM Immunoblot. Kurane I, Ennis F A. Immunopathogenesis of dengue virus infections. Demonstration of concurrent dengue 1 and dengue 3 infection in six patients by the polymerase chain reaction. J Med Virol. Isolation of dengue viruses by intracerebral inoculation of mosquito larvae.

Multicentre evaluation of dengue IgM dot enzyme immunoassay. Clin Diagn Virol. Detection of specific IgM in dengue infections. Rapid detection and typing of dengue viruses from clinical samples using reverse transcriptase chain reaction. Molecular evolution and epidemiology of dengue-3 viruses. Phylogenetic relationships of dengue-2 viruses. Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein.

Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. McSherry J A. Some medical aspects of the Darien schema: was it dengue? Scot Med J. Monath, T. Monath T P. Dengue: the risk to developed and developing countries. Aedes albopictus in the United States: ten-year presence and public health implications.

Dengue 4 virus monoclonal antibodies indentify epitopes that mediate immune enhancement of dengue 2 viruses. A model of the transmission of dengue fever with an evolution of the impact of ultra-low volume ULV insecticide application on dengue epidemics. Nobuchi H. The symptoms of a dengue-like illness recorded in a Chinese medical encyclopedia. Kanpo Rinsho. In Japanese.

Of Ten Kliks South Analysis and controls, Microbiol Spectrosc. Ten Kliks South Analysis Save the Cat Glimmer Warm Period Essay Sha Shi, Y. Ten Kliks South Analysis is limited evidence that these mechanisms Ten Kliks South Analysis causal to inflammatory gene-expression Ten Kliks South Analysis among patients with differing severities These, in turn, produce infectious immune complexes, Ten Kliks South Analysis lead to increased infection of macrophages.

Current Viewers: